Status:
RECRUITING
Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Glucose
Metabolism
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to understand how cells of the immune system use the common sugar glucose to fuel energy production and as a building block within the cell. Investigators will intravenous...
Eligibility Criteria
Inclusion
- Adults aged 18 or older
Exclusion
- Pregnant
- Prisoner or in police custody
- Uncontrolled hyperglycemia/diabetes
- Current participation in another study where the total volume of blood drawn, when added to this study blood draw volume, exceeds 500cc in an 8 week period
- Any medical issue or pharmacologic exposure which, in the opinion of the study investigator, that might interfere with the study objectives
- Any reason which, in the opinion of the study investigator, adds additional risk to the participant
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT06930976
Start Date
October 1 2025
End Date
June 30 2027
Last Update
November 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37212